IPST vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

IPST

51.9
AI Score
VS
IPST Wins

HIVE

40.3
AI Score

Investment Advisor Scores

IPST

52score
Recommendation
HOLD

HIVE

40score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IPST HIVE Winner
Forward P/E 1.2204 62.8931 IPST
PEG Ratio 0 0 Tie
Revenue Growth 60.7% 73.5% HIVE
Earnings Growth 0.0% -99.9% IPST
Tradestie Score 51.9/100 40.3/100 IPST
Profit Margin 0.0% -98.5% IPST
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

IPST 1M: -25.2% · 3M: +18.9% HIVE 1M: +9.4% · 3M: -12.0%

Current Technical Phase

IPST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.5 · Price: $3.08

HIVE

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 46

RSI (14): 46.5 · Price: $2.98

Fundamentals Snapshot

Metric IPST HIVE
Market Cap — —
Forward P/E 0.6 -5.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.6% 0.7%
Gross Margin 0.6% 0.4%
Operating Margin -1.1% -0.6%
EPS -291.36 -1.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IPST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.